Hot Products
0102030405
Benfotiamine: China Suppliers & Factory of Lipid-Soluble Vitamin B1 with Enhanced Bioavailability
C19H23N4O6PS
As a synthetic derivative of vitamin B1 (thiamine), benfotiamine significantly surpasses ordinary vitamin B1 in bioavailability, targeting and clinical efficacy through structural optimization and pharmacokinetic improvement. The specific advantages are as follows:
1
Structural Innovation: Lipid-Soluble Modification Breaks Through Absorption Limitations
Ordinary vitamin B1 (thiamine) is a water-soluble molecule that relies on intestinal sodium-dependent carriers (ThTr1/2) for active transport. It has a low absorption rate (<5%) and is easily saturated. High doses are easily excreted.
Benfotiamine is converted into a lipid-soluble prodrug by introducing benzoyl and phosphate groups (structural formula C19H23N4O6PS), which can bypass carrier restrictions and directly penetrate intestinal mucosal cells through passive diffusion.
Reference: J Clin Pharmacol, 2008
Benfotiamine is converted into a lipid-soluble prodrug by introducing benzoyl and phosphate groups (structural formula C19H23N4O6PS), which can bypass carrier restrictions and directly penetrate intestinal mucosal cells through passive diffusion.
>80%
Absorption Efficiency
3–5×
Bioavailability vs. Ordinary B1
<5%
Ordinary B1 Absorption Rate
2
Pharmacokinetic Advantages: Long-Term Effect and Tissue Targeting
Ordinary B1 has a short half-life in the blood (about 3.5 hours) and is easily cleared quickly by the kidneys. Benfotiamine is hydrolyzed into active thiamine by phosphatase in the body and further converted into thiamine pyrophosphate (TPP). Its lipid solubility makes it easier to accumulate in the phospholipid layer of the cell membrane, prolonging the duration of action.
Its ability to penetrate the blood-brain barrier and nerve sheath is 8–10 times that of ordinary B1, and it can effectively act on the central and peripheral nervous systems.
Reference: Neurochem Res, 2016
>6 hrs
Benfotiamine Half-Life
~3.5 hrs
Ordinary B1 Half-Life
8–10×
BBB & Nerve Sheath Penetration
Reference: Neurochem Res, 2016
3
Metabolic Regulation: Multi-Target Inhibition of Glucotoxic Damage
In a hyperglycemic environment, ordinary B1 is difficult to effectively inhibit abnormal glucose metabolism pathways due to poor tissue permeability. Benfotiamine shows unique advantages through the following mechanisms:
■
Blocking AGEs Generation: Inhibiting hexosamine and polyol pathways, reducing the accumulation of advanced glycation end products (AGEs), and alleviating axonal damage in diabetic neuropathy.
Reference: Diabetes, 2010
Reference: Diabetes, 2010
■
Anti-Inflammatory & Antioxidant: Downregulating the activity of NF-κB and TXNIP/NLRP3 inflammasomes, reducing inflammatory factors such as IL-6 and TNF-α, while enhancing glutathione reductase activity and alleviating oxidative stress.
■
Mitochondrial Protection: Restoring the function of pyruvate dehydrogenase complex (PDH), improving the efficiency of tricarboxylic acid cycle, and reducing lactic acid accumulation.
4
Clinical Efficacy: High-Dose Tolerance and Deep Repair
Ordinary B1 requires extremely high doses (≥300 mg/day) to treat diabetic neuropathy, but its efficacy is limited due to its absorption rate. Benfotiamine can stably increase tissue TPP concentration within the dose range of 150–600 mg/day.
No report of liver and kidney toxicity has been documented at therapeutic doses.
Reference: Diabetes Care, 2005
+2.1 m/s
Nerve Conduction Velocity vs. Placebo
−40%
VAS Pain Score Reduction
150–600 mg
Effective Daily Dose Range
Reference: Diabetes Care, 2005
5
Stability and Compatibility of Preparations
Benfotiamine is significantly more stable than ordinary B1 in an acidic environment (pH 2.0–4.0):
It is compatible with a variety of multivitamins or drug preparations. Its lipid-soluble properties support the development of delivery systems such as nanoemulsions and liposomes, further improving the efficiency of targeted delivery.
<5%
Benfotiamine Degradation Rate
>30%
Ordinary B1 Degradation Rate
?
Frequently Asked Questions (FAQ)
Q1
What is benfotiamine and how does it differ from regular vitamin B1?
Benfotiamine is a synthetic, lipid-soluble derivative of vitamin B1 (thiamine). Unlike regular water-soluble thiamine, which depends on intestinal carriers for absorption (with an absorption rate below 5%), benfotiamine bypasses these limitations through passive diffusion, achieving an absorption efficiency of over 80% and a bioavailability 3–5 times higher than ordinary B1.
Q2
Why is benfotiamine more effective for diabetic neuropathy than standard thiamine?
Benfotiamine's superior tissue penetration — especially into nerve tissues and through the blood-brain barrier (8–10× greater than ordinary B1) — allows it to more effectively inhibit abnormal glucose metabolism pathways, block AGE formation, and reduce nerve-damaging oxidative stress and inflammation. Clinical trials have demonstrated significant improvements in nerve conduction velocity and pain scores compared to placebo.
Q3
What is the recommended dosage range for benfotiamine?
Clinical trials have demonstrated effective results within a dose range of 150–600 mg/day. Within this range, benfotiamine stably increases tissue thiamine pyrophosphate (TPP) concentrations without reported liver or kidney toxicity, making it suitable for long-term supplementation under medical guidance.
Q4
How does benfotiamine protect against high blood sugar damage at a cellular level?
Benfotiamine works through multiple mechanisms: it blocks the production of advanced glycation end products (AGEs), suppresses pro-inflammatory pathways (NF-κB, TXNIP/NLRP3), boosts antioxidant activity via glutathione reductase, and restores mitochondrial energy metabolism by activating the pyruvate dehydrogenase complex (PDH). Together, these actions reduce glucotoxic cellular damage associated with diabetes.
Q5
Is benfotiamine stable in acidic environments such as the stomach?
Yes. Benfotiamine demonstrates excellent acid stability, with a degradation rate of less than 5% at pH 2.0–4.0, compared to over 30% for ordinary vitamin B1 under the same conditions. This stability ensures that more of the active compound survives gastric transit and reaches the intestine for absorption.
Q6
Can benfotiamine be combined with other vitamins or medications?
Benfotiamine is well-compatible with a wide range of multivitamin formulations and pharmaceutical preparations. Its lipid-soluble nature also makes it suitable for advanced drug delivery systems such as nanoemulsions and liposomes, which can further enhance targeted delivery and therapeutic efficiency.